Pyxis Oncology, Inc. (PYXS) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 45.57M | 72.11M | 83.07M | 99.96M | 111.87M | 132.44M | 148.87M | 161.04M | 172.38M | 124.6M | 139.09M | 149.3M | 156.18M | 186.61M | 202.81M | 226.59M | 251.26M | 278.67M | 134.34M | 142.94M |
| Cash & Short-Term Investments | 42.49M | 66.86M | 77.73M | 88.94M | 105.43M | 126.93M | 144.82M | 155.72M | 157.03M | 119.3M | 132.97M | 142.66M | 149.35M | 179.29M | 198.54M | 223.35M | 247.09M | 274.74M | 133.48M | 142.47M |
| Cash Only | 7.24M | 15.42M | 10.39M | 10.73M | 12.76M | 19.47M | 12.06M | 25.07M | 27.97M | 9.66M | 14.71M | 25.9M | 53.06M | 179.29M | 198.54M | 223.35M | 247.09M | 274.74M | 133.48M | 142.47M |
| Short-Term Investments | 35.25M | 51.44M | 67.34M | 78.21M | 92.67M | 107.46M | 132.76M | 130.65M | 129.06M | 109.63M | 118.25M | 116.77M | 96.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 700K | 0 | 3M | 0 | 0 | 0 | 0 | 8M | 21K | 0 | 0 | 0 | 598K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | 5.83 | - | 96.81 | - | - | - | - | 22.6 | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.08M | 4.55M | 5.34M | 8.01M | 6.44M | 4.75M | 4.05M | 5.31M | 1.47M | 4.27M | 6.13M | 6.64M | 6.83M | 5.41M | 1.47M | 1.47M | 1.47M | 1.56M | 0 | 0 |
| Total Non-Current Assets | 18.73M | 19.41M | 22.53M | 23.26M | 24M | 24.74M | 46.44M | 47.35M | 47.84M | 49.12M | 47.6M | 25.93M | 26.62M | 24.77M | 21.09M | 15.97M | 1.44M | 1.35M | 5.15M | 4.11M |
| Property, Plant & Equipment | 18.73M | 19.41M | 20.1M | 20.77M | 21.45M | 22.14M | 22.82M | 23.68M | 24.11M | 24.81M | 25.3M | 25.93M | 26.62M | 24.77M | 21.09M | 15.97M | 995K | 1.24M | 1.54M | 1.85M |
| Fixed Asset Turnover | - | 0.56x | - | 0.13x | - | - | - | - | 0.66x | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 2.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 2.43M | 2.49M | 0 | 2.6M | 0 | 0 | 23.73M | 24.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 449K | 109K | 3.61M | 2.25M |
| Total Assets | 64.3M | 91.52M | 105.6M | 123.22M | 135.87M | 157.18M | 195.31M | 208.39M | 220.22M | 173.73M | 186.69M | 175.23M | 182.8M | 211.38M | 223.9M | 242.56M | 252.7M | 280.02M | 139.49M | 147.05M |
| Asset Turnover | - | 0.11x | - | 0.02x | - | - | - | - | 0.08x | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -52.67% | -41.77% | -45.93% | -40.87% | -38.3% | -9.52% | 4.62% | 18.92% | 20.47% | -17.81% | -16.62% | -27.76% | -27.66% | -24.51% | 60.51% | 64.95% | - | 2658.56% | - | - |
| Total Current Liabilities | 16.53M | 21.13M | 19.38M | 17.68M | 14.43M | 17.68M | 20.32M | 16.9M | 14.14M | 25.76M | 28.33M | 9.22M | 11.6M | 31.63M | 19.09M | 14.92M | 19.19M | 18.71M | 16.84M | 8.41M |
| Accounts Payable | 4.99M | 10.88M | 9.76M | 9.41M | 2.85M | 4.86M | 4.87M | 5.47M | 2.29M | 3.9M | 3.31M | 1.3M | 4.03M | 7.1M | 5.51M | 7.82M | 2.06M | 11.95M | 1.93M | 1.27M |
| Days Payables Outstanding | 1.56K | -2.2K | - | - | - | - | - | - | 592.84 | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.76M | 1.69M | 1.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.66M | 7.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.79M | 8.55M | 8M | 0 | 0 | 4.63M | 0 | 0 | 0 | 5.58M | 0 | 0 | 0 | 5.33M | 0 | 0 | 0 | 3.23M | 9.12M | 4.43M |
| Current Ratio | 2.76x | 3.41x | 4.29x | 5.65x | 7.75x | 7.49x | 7.33x | 9.53x | 12.19x | 4.84x | 4.91x | 16.18x | 13.46x | 5.90x | 10.62x | 15.19x | 13.10x | 14.90x | 7.98x | 16.99x |
| Quick Ratio | 2.76x | 3.41x | 4.29x | 5.65x | 7.75x | 7.49x | 7.33x | 9.53x | 12.19x | 4.84x | 4.91x | 16.18x | 13.46x | 5.90x | 10.62x | 15.19x | 13.10x | 14.90x | 7.98x | 16.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 16.5M | 16.98M | 17.44M | 17.89M | 18.33M | 18.75M | 21.31M | 21.7M | 21.92M | 22.26M | 20.41M | 20.73M | 19.04M | 18.92M | 16.05M | 15.68M | 0 | 0 | 194.09M | 196.22M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 16.5M | 16.98M | 17.44M | 17.89M | 18.33M | 18.75M | 19.15M | 19.53M | 19.76M | 20.1M | 20.41M | 20.73M | 19.04M | 18.92M | 16.05M | 15.68M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2.16M | 2.16M | 0 | 2.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 194.09M | 196.22M |
| Total Liabilities | 33.03M | 38.11M | 36.83M | 35.57M | 32.76M | 36.43M | 41.63M | 38.59M | 36.06M | 48.02M | 48.75M | 29.95M | 30.64M | 50.55M | 35.15M | 30.6M | 19.19M | 18.71M | 210.93M | 204.64M |
| Total Debt | 18.26M | 18.67M | 19.07M | 19.46M | 19.84M | 20.2M | 20.54M | 20.87M | 20.78M | 21.33M | 21.62M | 21.26M | 20.25M | 18.92M | 16.05M | 15.68M | 0 | 165K | 325K | 481K |
| Net Debt | 11.02M | 3.25M | 8.68M | 8.73M | 7.08M | 727K | 8.48M | -4.2M | -7.19M | 11.67M | 6.9M | -4.64M | -32.81M | -160.37M | -182.49M | -207.67M | -247.09M | -274.57M | -133.15M | -141.99M |
| Debt / Equity | 0.58x | 0.35x | 0.28x | 0.22x | 0.19x | 0.17x | 0.13x | 0.12x | 0.11x | 0.17x | 0.16x | 0.15x | 0.13x | 0.12x | 0.09x | 0.07x | - | 0.00x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 31.27M | 53.41M | 68.78M | 87.64M | 103.1M | 120.75M | 153.68M | 169.79M | 184.16M | 125.7M | 137.95M | 145.28M | 152.16M | 160.82M | 188.75M | 211.97M | 233.51M | 261.31M | -71.44M | -57.59M |
| Equity Growth % | -69.67% | -55.77% | -55.25% | -48.38% | -44.01% | -3.94% | 11.41% | 16.88% | 21.03% | -21.84% | -26.91% | -31.46% | -34.84% | -38.46% | 364.21% | 468.07% | 3608.34% | 1770.27% | - | - |
| Book Value per Share | 0.49 | 0.86 | 1.10 | 1.42 | 1.69 | 1.99 | 2.53 | 2.81 | 3.59 | 2.81 | 3.34 | 3.78 | 4.30 | 4.60 | 5.80 | 6.53 | 7.23 | 8.23 | -2.25 | -1.81 |
| Total Shareholders' Equity | 31.27M | 53.41M | 68.78M | 87.64M | 103.1M | 120.75M | 153.68M | 169.79M | 184.16M | 125.7M | 137.95M | 145.28M | 152.16M | 160.82M | 188.75M | 211.97M | 233.51M | 261.31M | -71.44M | -57.59M |
| Common Stock | 63K | 63K | 62K | 62K | 62K | 60K | 59K | 59K | 59K | 45K | 44K | 39K | 37K | 34K | 32K | 32K | 32K | 32K | 2K | 2K |
| Retained Earnings | -466.45M | -443.18M | -425.07M | -403.07M | -384.71M | -363.56M | -327.99M | -306.78M | -289.48M | -286.23M | -270.63M | -247.58M | -231.68M | -212.44M | -176.33M | -148.66M | -123.1M | -91.72M | -74.89M | -60.71M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 53K | 69K | -5K | 49K | 170K | 351K | -102K | -60K | 63K | -105K | -85K | 696K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |